| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 27655-40-9 | 5-异喹啉磺酸 | 5-Isoquinolinesulfonic acid |  | C9H7NO3S | 详情 | 供应商 |
| 105628-07-7 | 盐酸法舒地尔; 六氢-1-(5-异喹啉磺酰基)-1H-1,4-二氮杂卓盐酸盐 | Fasudil hydrochloride; 1-(5-Isoquinolinesulfonyl)homopiperazine hydrochloride; Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine monohydrochloride |  | C14H18ClN3O2S | 详情 | 供应商 |
| 103745-39-7 | 1-(5-硫代异喹啉)哌嗪二盐酸盐; 盐酸法舒地尔; 六氢-1-(5-异喹啉磺酰基)-1H-1,4-二氮杂卓盐酸盐 | Fasudil; Fasudil HCl; 1H-1,4-Diazepine,hexahydro-1-(5-isoquinolinylsulfonyl)- (9CI); 1-(5-Isoquinolinesulphonyl)homopiperazine; AT 877; Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine; HA 1077; |  | C14H17N3O2S | 详情 | 供应商 |
| 84468-17-7 | N-(2-氨乙基)-5-异喹啉磺酰二盐酸盐 | 5-Isoquinolinesulfonamide,N-(2-aminoethyl)-; H 9; H 9(kinase inhibitor); Isoquinoline-5-sulfonic acid N-(2-aminoethyl)amide; N-(2-Aminoethyl)-5-isoquinolinesulfonamide; N-(2-Aminoethyl)-5-isoquinolinesulfonic acid amide; Protein kinase inhibitorH-9 |  | C11H13N3O2S | 详情 | 供应商 |
| 127243-85-0 | H-89二盐酸盐; N-[2-[P-溴苯丙烯盐基氨基]乙基]-5-异喹啉磺酰胺 | 5-Isoquinolinesulfonamide,N-[2-[[3-(4-bromophenyl)-2-propen-1-yl]amino]ethyl]-; 5-Isoquinolinesulfonamide,N-[2-[[3-(4-bromophenyl)-2-propenyl]amino]ethyl]- (9CI); H 89; H 89(pharmaceutical); Protein kinase inhibitor H89 |  | C20H20BrN3O2S | 详情 | 供应商 |
| 127191-97-3 | 1-[N,O-二(5-异喹啉磺酰基)-N-甲基-L-型酪氨酸]-4-苯基哌嗪 | KN-62; KN-62; 4-[(2S)-2-[(5-ISOQUINOLINYLSULFONYL)METHYLAMINO]-3-OXO-3-(4-PHENYL-1-PIPERAZINYL)PROPYL] PHENYL ISOQUINOLINESULFONIC ACID ESTER; 1-[N,O-BIS-(5-ISOQUINOLINESULFONYL)-N-METHYL-L-TYROSYL]-4-PHENYLPIPERAZINE; (S)-5-ISOQUINOLINESULFONIC ACID 4-(2-[(5-ISOQUINOLINYLSULFONYL)METHYLAMINO]- 3-OXO-3-[4-PHENYL-1-PIPERAZINYL]PROPYL)PHENYL ESTER; 1-(N,O-BIS-(5-ISOQUINOLINESULFONYL)-*N-M ETHYL-L-TYR; KN-62 97%; KN-62, 99+%; 4-((2S)-2-((5-isoquinolinylsulfonyl)methylamino)-3-oxo-3-(4-phenyl-1-piperazinyl)propyl)phenylisoquinolinesulfonicacid |  | C38H35N5O6S2 | 详情 | 供应商 |
